Ronald Peck - 12 Aug 2022 Form 4/A - Amendment Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Medical Officer
Signature: /s/ Matthew Batters, as attorney-in-fact for Ronald Peck
Issuer symbol: ARVN
Transactions as of: 12 Aug 2022
Net transactions value: -$68,994
Form type: 4/A - Amendment
Filing time: 16 Aug 2022, 17:25:16 UTC
Date Of Original Report: 16 Aug 2022
Previous filing: 04 Mar 2022
Next filing: 24 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARVN	Common Stock	Options Exercise		+4,010	+74%		9,412	12 Aug 2022	Direct	F1
transaction	ARVN	Common Stock	Sale	$68,994	-1,258	-13%	$54.84	8,154	12 Aug 2022	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARVN	Restricted Stock Units	Options Exercise	$0	-4,010	-50%	$0.000000	4,010	12 Aug 2022	Common Stock	4,010		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
F2	This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
F3	This amendment is being filed to correct the sales price reported on the reporting person's Form 4 filed on August 16, 2022.
F4	On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.